计算溶液所需的质量、体积或浓度。
| 活性类型 | 活性值-log(M) | 作用机制 | 期刊 | 参考文献(PubMed IDs) |
|---|
,适用于对基线干扰要求严格的色谱和分析工作流程。
-80℃储存。特低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
AR9281(APAU)是一种有效的,选择性可溶性环氧水解酶(S-EH)抑制剂。AR-9281 可抑制人 SEH(HsEH)和鼠 SEH(MsEH),IC50 值分别为 13.8 nM 和 1.7 nM。AR9281 可用于炎症,高血压和 2 型糖尿病的研究。
AR9281 (APAU) is a potent, selective and orally active soluble epoxide hydrolase (s-EH) inhibitor. AR-9281 can inhibits human sEH (HsEH) and murine sEH (MsEH) with IC 50 values of 13.8 nM and 1.7 nM, respectively. AR9281 can be used for the research of inflammation, hypertension and type 2 diabetes
In Vitro
AR-9281 (APAU) has inhibitory activity for human sEH (HsEH) and murine sEH (MsEH) with IC 50 values of 13.8 nM and 1.7 nM, respectively. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
AR-9281 (APAU) (oral, 150-200 mg/dL, for 6 weeks) enhances the therapeutic effects of EETs, slows progression of hyperglycemia, protects the myocyte structure, and reduces Ca 2+ dysregulation and SERCA remodeling in hyperglycemic rats. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: T2DM rat modelDosage: 150-200 mg/dL Administration: oral(drinking), for 6 weeks Result: Attenuated the progressive increase of blood glucose concentration and preserved mitochondrial structure and myofibril morphology in cardiac myocytes. Protected the intracellular Ca 2+ effector system. Had less downregulation of sarco(endo)plasmic reticulum Ca 2+ ATPase (SERCA) and lowed expression of hypertrophic markers.
IC50& Target:IC50: 13.8 nM (HsEH),1.7 nM (MsEH)
| ALogP | 2.1 |
|---|
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
| 分析证书 | A655278 |